Search clinical trials for: Endothelium-Dependent Relaxing Factors

Total 31549 results

French National Agency for Research on AIDS and...
Hoffmann-La Roche

Terminated

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

HIV Infections | Giant Lymph Node Hyperplasia
Institute for Clinical and Experimental Medicine
Ministry of Health, Czech Republic

Unknown

Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes

Diabetes Mellitus, Type 1

Czech Republic
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis
Romark Laboratories L.C.

Completed

Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C

Chronic Hepatitis C

Egypt
Rabin Medical Center

Unknown

Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women

Alopecia

Israel
The Center for Rheumatic Disease, Allergy, & Immunology
Grifols Therapeutics LLC

Completed

Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections

Infections | IgG Deficiency

United States
Institute of Child Health

Unknown

PRINTO (the Paediatric Rheumatology International Trials Organisation)

Juvenile Idiopathic Arthritis

United Kingdom
Celgene Corporation
Prologue Research International

Completed

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Celgene Corporation

Completed

Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)

Prostate Cancer

United States
University Hospital Freiburg

Completed

Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients

Corneal Transplantation
AZ-VUB
Fund for Scientific Research, Flanders, Belgium; Belgian Government

Terminated

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

Type 1 Diabetes | Islet Transplantation

Belgium
University of Turin, Italy

Completed

Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients

Multiple Myeloma

Italy
Alexion Pharmaceuticals

Completed

Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Hemoglobinuria, Paroxysmal

United States, Australia, Belgium, Canada, Germany, Italy, United Kingdom, France, Ireland, Netherlands, Sweden, Switzerland
University of Turin, Italy

Completed

Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma

Multiple Myeloma

Italy
University of Siena
Merck Sharp & Dohme LLC

Unknown

Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

Skin Diseases | Pneumonia | Bacteremia | Urinary Tract Infections | Enterobacteriaceae Infections

Italy
The Guenther Dermatology Research Centre
Biogen

Completed

Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis

Psoriasis | Palmoplantaris Pustulosis | Pustulosis of Palms and Soles | Pustular Psoriasis of Palms and Soles | Pustulosis Palmaris et Plantaris

Canada
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Multiple Myeloma | Cutaneous Lymphoma

Australia
Hospices Civils de Lyon

Unknown

CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors

Microscopic Polyangiitis | Polyarteritis Nodosa

Switzerland
Hospices Civils de Lyon

Unknown

CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors

Churg-Strauss Syndrome

Switzerland
AGO Study Group

Completed

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer
Shahid Beheshti University of Medical Sciences

Unknown

Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD

Neovascular Age-Related Macular Degeneration

Iran, Islamic Republic of
Hordinsky, Maria K., MD

Completed

Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice

Alopecia

United States
Hordinsky, Maria K., MD
3M; National Alopecia Areata Foundation

Completed

Aldara for the Treatment of Extensive Alopecia Areata

Alopecia Areata

United States
AGO Study Group

Completed

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Rajavithi Hospital
Rajavithi Biomolecular Research Center

Completed

Botulism Outbreak in Thailand (Episode II)

Botulism

Thailand
Meiji University of Oriental Medicine
Kyoto Prefectural University of Medicine

Terminated

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan

Allergic Conjunctivitis

Japan
University of Ottawa
Canadian Institutes of Health Research (CIHR)

Unknown

Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair

Myocardial Infarction

Canada
Hospital Universitario Ramon y Cajal
Novartis; Astellas Pharma Inc

Unknown

Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus

Kidney Diseases

Spain
Gruppo Italiano Studio Linfomi

Completed

Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab

Follicular Lymphoma

Italy
UMC Utrecht
University Medical Center Groningen; Dutch Arthritis Association

Completed

Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome

Lupus Erythematosus, Systemic | Sjogren's Syndrome

Netherlands
University of Bern
University of Zurich

Completed

Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization

Coronary Heart Disease

Switzerland
Medical University of Vienna

Unknown

Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma

Lymphoma, Mantle-Cell

Austria
Centre Hospitalier Universitaire de Nice

Terminated

Treatment of Oral Erosive Lichen Planus With Pimecrolimus Cream

Oral Erosive Lichen Planus
Washington University School of Medicine

Terminated

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

Kidney Transplantation

United States
Nanjing Medical University

Unknown

Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Cancer.

Cancer

China
Shahid Beheshti University of Medical Sciences

Completed

Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy

Proliferative Vitreoretinopathy

Iran, Islamic Republic of
Aarhus University Hospital Skejby
Aarhus University Hospital; Regional Hospital Holstebro

Unknown

Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors

Polycystic Ovary Syndrome
Odense University Hospital

Completed

Rituximab in the Treatment of Graves' Disease

Thyroid Associated Ophthalmopathy | Graves´ Disease

Denmark
University of Magdeburg

Unknown

Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Lymphoma, High-Grade

Germany
University of Magdeburg

Unknown

Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma

Non-Hodgkin's Lymphoma

Germany
University Hospital Muenster
Hoffmann-La Roche

Unknown

CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.

Psoriasis

Germany
Association of Urologic Oncology (AUO)
Eli Lilly and Company

Unknown

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Carcinoma, Transitional Cell | Bladder Cancer

Germany
The Alvin and Lois Lapidus Cancer Institute
Ortho Biotech Products, L.P.

Unknown

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Lymphoma, Non-Hodgkin | Diffuse Large B Cell Lymphoma

United States
La Jolla Pharmaceutical Company

Completed

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

Autoimmune Diseases | Systemic Lupus Erythematosus | Lupus Nephritis | Immunologic Diseases | Lupus Glomerulonephritis

United States, Austria, Canada, France, Germany, Italy, Mexico, Spain, Sweden, United Kingdom
Finnish Institute for Health and Welfare
Merck Sharp & Dohme LLC; Wyeth-Lederle Vaccines; Pasteur Merieux Connaught

Completed

Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes

Pneumococcal Infections | Otitis Media

Finland
Astellas Pharma Inc

Completed

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
Astellas Pharma Inc

Completed

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
Eli Lilly and Company

Terminated

Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer

Ovarian Cancer | Peritoneal Cancer

United States
Technische Universität Dresden

Completed

Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.

Healthy Subjects

Germany
Technische Universität Dresden

Completed

Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.

Healthy Subjects

Germany

Search clinical trials for: Endothelium-Dependent Relaxing Factors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations